Public stakeholder meeting: approval, safety monitoring and impact of COVID-19 vaccines in the EU

Date: 26/03/2021
Location: Virtual meeting, 13:00 - 15:15 (CET)

Event summary

This third public meeting updated to EU citizens about the continued assessment, approval and safety monitoring of COVID-19 vaccines, and their expected impact at community level.

It covered: 

  • COVID-19 vaccines approved in the EU and those currently under review;
  • post-authorisation activities, including emerging safety data since EU authorisation of the first COVID-19 vaccines;
  • ongoing work to address new variants;
  • the expected impact of COVID-19 vaccination on our society;
  • transparency and the publication of clinical data for COVID-19 vaccines.

The event also allowed the public and stakeholders to further inform EMA of their needs, expectations and any concerns.

Video recordings

Full video recording

 

Update on approved and candidate COVID-19 vaccines in the EU, Marco Cavaleri (EMA)

 

Vaccines safety monitoring – update on emerging data since EU authorisations, Peter Arlett (EMA)

 

Expected impact of COVID-19 vaccination in the European Union, Edoardo Colzani (ECDC)

 

Transparency and publication of clinical data for COVID-19 vaccines, Melanie Carr (EMA)

How useful was this page?

Add your rating
Average
6 ratings
4 ratings
1 rating
2 ratings